Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington's Disease: Preclinical Evidence with the p75 NTR Ligand LM11A-31.

T A Tishler, G Bartzokis, MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cellular and Molecular Biology. ,vol. 46, pp. 821- 833 ,(2000)

Minghua Chen, Victor O. Ona, Mingwei Li, Robert J. Ferrante, Klaus B. Fink, Shan Zhu, Jie Bian, Lei Guo, Laurie A. Farrell, Steve M. Hersch, Wendy Hobbs, Jean-Paul Vonsattel, Jang-Ho J. Cha, Robert M. Friedlander, Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nature Medicine. ,vol. 6, pp. 797- 801 ,(2000) , 10.1038/77528

Cristina Sánchez-Castañeda, Ferdinando Squitieri, Margherita Di Paola, Michael Dayan, Martina Petrollini, Umberto Sabatini, The role of iron in gray matter degeneration in Huntington's disease: A magnetic resonance imaging study Human Brain Mapping. ,vol. 36, pp. 50- 66 ,(2015) , 10.1002/HBM.22612

Chiara Zuccato, Manuela Marullo, Paola Conforti, Marcy E MacDonald, Marzia Tartari, Elena Cattaneo, RESEARCH ARTICLE: Systematic Assessment of BDNF and Its Receptor Levels in Human Cortices Affected by Huntington's Disease Brain Pathology. ,vol. 18, pp. 225- 238 ,(2007) , 10.1111/J.1750-3639.2007.00111.X

Robert A. Cherny, Scott Ayton, David I. Finkelstein, Ashley I. Bush, Gawain McColl, Stephen M. Massa, PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease. Journal of Huntington's disease. ,vol. 1, pp. 211- 219 ,(2012) , 10.3233/JHD-120029

Aaron Sturrock, Corree Laule, Katy Wyper, Ruth A Milner, Joji Decolongon, Rachelle Dar Santos, Allison J Coleman, Kimberley Carter, Susan Creighton, Natalie Bechtel, Stefan Bohlen, Ralf Reilmann, Hans J Johnson, Michael R Hayden, Sarah J Tabrizi, Alex L Mackay, Blair R Leavitt, None, A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Movement Disorders. ,vol. 30, pp. 393- 401 ,(2015) , 10.1002/MDS.26118

Edina Silajdžić, Melinda Rezeli, Ákos Végvári, Nayana Lahiri, Ralph Andre, Anna Magnusson-Lind, Rajasree Nambron, Eirini Kalliolia, György Marko-Varga, Thomas T. Warner, Thomas Laurell, Sarah J. Tabrizi, Maria Björkqvist, A Critical Evaluation of Inflammatory Markers in Huntington's Disease Plasma Journal of Huntington's disease. ,vol. 2, pp. 125- 134 ,(2013) , 10.3233/JHD-130049

Govinda R. Poudel, Julie C. Stout, Juan F. Domínguez D, Louisa Salmon, Andrew Churchyard, Phyllis Chua, Nellie Georgiou-Karistianis, Gary F. Egan, White matter connectivity reflects clinical and cognitive status in Huntington's disease Neurobiology of Disease. ,vol. 65, pp. 180- 187 ,(2014) , 10.1016/J.NBD.2014.01.013

Edward Wild, Anna Magnusson, Nayana Lahiri, Ulrika Krus, Michael Orth, Sarah J Tabrizi, Maria Björkqvist, Abnormal peripheral chemokine profile in Huntington's disease. PLOS Currents. ,vol. 3, ,(2011) , 10.1371/CURRENTS.RRN1231

Graziella Orrù, William Pettersson-Yeo, Andre F. Marquand, Giuseppe Sartori, Andrea Mechelli, Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review Neuroscience & Biobehavioral Reviews. ,vol. 36, pp. 1140- 1152 ,(2012) , 10.1016/J.NEUBIOREV.2012.01.004